论文部分内容阅读
目的:探讨腹腔镜联合口服米非司酮治疗子宫内膜异位症临床疗效。方法:随机选取本院2013年至2014年收治的子宫内膜异位症患者118例,均分为对照组和观察组,对照组患者采用腹腔镜进行临床治疗,观察组患者在采用腹腔镜治疗的基础上,在术后3 d开始口服米非司酮片,对比两组患者的临床疗效、不良反应和术后1年受孕情况。结果:观察组患者治疗后,其治疗总有效率明显高于对照组患者(P<0.05),观察组患者疾病复发比例明显降低,同时其治疗后受孕比例高于对照组患者(P<0.05)。对照组患者出现不良反应略高于观察组患者,但差异无统计学意义(P>0.05)。结论:腹腔镜联合米非司酮治疗子宫内膜异位症,具有较为满意的治疗效果,并且能够明显提高患者的预后效果和受孕率,降低疾病的复发和不良反应的发生。
Objective: To investigate the clinical efficacy of laparoscopy combined with oral mifepristone in the treatment of endometriosis. Methods: A total of 118 patients with endometriosis who were treated in our hospital from 2013 to 2014 were selected randomly, which were divided into control group and observation group. Patients in control group were treated by laparoscopy, while patients in observation group were treated by laparoscopy , On the basis of 3 days after oral administration of mifepristone tablets, compared two groups of patients with clinical efficacy, adverse reactions and 1 year after pregnancy. Results: After treatment, the total effective rate of observation group was significantly higher than that of control group (P <0.05), and the proportion of disease recurrence in observation group was significantly lower than that of control group (P <0.05) . Adverse reactions in the control group were slightly higher than those in the observation group, but the difference was not statistically significant (P> 0.05). Conclusion: Laparoscopy combined with mifepristone treatment of endometriosis has a more satisfactory therapeutic effect, and can significantly improve the prognosis of patients and pregnancy rate, reduce the incidence of recurrence and adverse reactions.